Spontaneous mutation in the COL6A2 gene causing Ullrich congenital muscular dystrophy type 1 in a Chinese child: A case report

Jiayi Li,Shuangzhu Lin,Qiong Wu,Jinhua Feng,Qiandui Chen,Kai Jiang
DOI: https://doi.org/10.1097/md.0000000000036398
IF: 1.6
2024-02-23
Medicine
Abstract:Ullrich muscular dystrophy is a congenital myopathy. The pathogenesis of this disease is related to a collagen synthesis disorder. The loss of association between the stroma and the basal layer may be a novel molecular pathological mechanism underlying muscular dystrophy. A key factor in the development of muscular dystrophy is the selective lack of collagen VI in the endomysium. Collagen VI is a ubiquitous extracellular matrix protein and is particularly enriched in the endomysium of skeletal muscle. It binds tightly with the basement membrane surrounding muscle cells to form a microfibrillary network, and is able to interact with several other matrix components. Collagen VI consists of 3 different alpha chains encoded by separate genes named COL6A1, COL6A2, and COL6A3. Mutations in the collagen VI gene causes 2 skeletal muscle disorders, namely, Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD) type 1. The COL6 gene ( COL6A1, COL6A2 , and COL6A3 ) variants cause defects in collagen function, and the main clinical manifestations are motor retardation, limb muscle weakness (proximal greater than distal), high palatal arch, slender limbs, proximal joint contracture, and distal joint laxity. Generally, in the neonatal period or early infancy [ 1 , 2 ] malnutrition implies that muscle histopathology shows features of necrosis and regeneration followed by adipose and fibrotic tissue genesis. Muscle biopsy may also show other nonspecific signs, such as fibrous atrophy, hypertrophy, and increased inflammation. We report a spontaneous mutation in the COL6A2 gene causing UCMD type 1 in a pediatric patient.
medicine, general & internal
What problem does this paper attempt to address?